| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. | Director | Restricted Stock Units | 3.75K | $5.4K | $0.72 | Jan 24, 2025 | Direct |
| Arbutus Biopharma Corp | President and CEO, Director | Stock Option (Right to Buy) | 310K | Mar 18, 2025 | Direct | ||
| Eloxx Pharmaceuticals, Inc. | Director | Common Stock | 15.8K | Jan 24, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | Mar 18, 2025 | 1 | $0 | 4 | Mar 20, 2025 | President and CEO, Director |
| ABUS | Arbutus Biopharma Corp | Feb 24, 2025 | 0 | $0 | 3 | Mar 6, 2025 | President and CEO, Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jan 24, 2025 | 2 | $0 | 4 | Jan 28, 2025 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Oct 16, 2024 | 1 | $0 | 4 | Oct 17, 2024 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jan 30, 2023 | 1 | $0 | 4 | Jan 31, 2023 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jul 1, 2022 | 0 | $0 | 3 | Jul 6, 2022 | Director |